TENOFOVIR DISOPROXIL FUMARATE
NDC 50268-758, tenofovir disoproxil fumarate, tablet, from AvPAK.
- Product NDC
- 50268-758
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090742
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50268-758 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TENOFOVIR DISOPROXIL FUMARATE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-758-12 | 50268075812 | 20 BLISTER PACK in 1 BOX (50268-758-12) / 1 TABLET in 1 BLISTER PACK (50268-758-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a215f64c-84de-0649-e053-2a95a90a9d59NADAC price for package 50268075812
GET /v1/drugs/nadac/50268075812
Use it
Look up 50268-758 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-758 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-758. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.